Eminent II Venture Capital

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 6, 2016	ACT Genomics	$12.5M Series B	CDIB Capital, Hotung Venture Group	Hua Nan Venture Capital, President International Development Corporation, UMC Capital
Aug 9, 2007	Nereus Pharmaceuticals	$45.0M Series D	BankInvest Biomedical Venture	Advent International, Alta Partners, Astellas Venture Management, Boston Life Science Venture Corporation, Forward Ventures, Gimv, HBM Healthcare Investments, InterWest Partners, Pacific Venture Group, Roche, Taiwan Global Biofund

Total Raised

N/A

Valuation

N/A